Statistics

Total Visits

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment106

Select a period of time:

Number of views in the range

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment32

Views

Views
November 20257
December 20254
January 20261
February 20260
March 20264
April 202610
May 20266
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States14
United Kingdom5
Brazil4
Angola1
Argentina1
Australia1
Chile1
Germany1
Algeria1
Mexico1
 

Top cities views

Views
Ashburn3
Annaba1
Bolton1
Charleston1
Chimbas1
Coyoacán1
El Paso1
Frankfurt am Main1
Lewisham1
Lima1